Latest news
PUBM Upgraded by Raymond James -- Rating Raised to Outperform - GuruFocusGuruFocus · Fri, 07 Aug 2026 14:33:07 GMTRaymond James Reaffirms Outperform on BDTX Amid Promising NSCLC Trial Data - GuruFocusGuruFocus · Thu, 06 Aug 2026 15:59:27 GMTBXMT Downgraded by Raymond James -- Rating Changed to Market Per - GuruFocusGuruFocus · Thu, 06 Aug 2026 13:26:23 GMTWTTR Downgraded by Raymond James -- Price Target Raised to $26 - GuruFocusGuruFocus · Thu, 06 Aug 2026 12:11:32 GMTCVEO Initiates Coverage On Raymond James -- Price Target Announced at $51 - GuruFocusGuruFocus · Wed, 05 Aug 2026 13:05:58 GMTVSH Initiated by Raymond James -- Rating Set to Outperform - GuruFocusGuruFocus · Tue, 04 Aug 2026 21:20:12 GMTCI Downgraded by Raymond James -- Price Target Lowered to $320 - GuruFocusGuruFocus · Tue, 04 Aug 2026 08:52:52 GMTALNY Upgraded by Raymond James -- Maintains Price Target at $420 - GuruFocusGuruFocus · Mon, 03 Aug 2026 23:24:02 GMT